MOTS-C is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
MOTS-C is being researched for skin applications. Translocates to the nucleus where it regulates gene expression through the Folate-AICAR-AMPK pathway. Activates antioxidant response elements (ARE) and interacts with NRF2 transcription factor to enha. Common dosages for this use range from 5-10 mg per week 2-3 times weekly.
Can MOTS-C Help With Skin?
MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is being researched for skin applications based on its mechanism as a Mitochondrial-derived peptide, metabolic regulator.
Translocates to the nucleus where it regulates gene expression through the Folate-AICAR-AMPK pathway. Activates antioxidant response elements (ARE) and interacts with NRF2 transcription factor to enhance cellular stress resistance. Improves insulin sensitivity and glucose metabolism through AMPK pathway activation, essentially mimicking exercise at the molecular level.
What Does the Research Show for MOTS-C and Skin?
First mitochondrial-derived peptide to enter human trials — a 4-week trial of 20 subjects showed glucose reduction and liver enzyme improvement. Extensive animal research documents metabolic, anti-aging, and exercise benefits. Listed by FDA as not approved for compounding.
The relevance to skin specifically comes from MOTS-C's effects on improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility.
What Protocol Is Used for Skin?
For skin applications, the standard MOTS-C protocol is 5-10 mg per week administered 2-3 times weekly via subcutaneous injection for 8-12 weeks with 8-12 week breaks.
Some researchers adjust dosing based on the specific skin application — see our MOTS-C dosage guide for full protocol details.
Can Stacking Improve Skin Results?
Pairs with SS-31 (another mitochondrial-targeting peptide) for enhanced mitochondrial biogenesis, and with 5-Amino-1MQ for comprehensive metabolic optimization.
What Side Effects Apply to Skin Use?
Generally well-tolerated. Mild injection site reactions and transient digestive disturbances at higher doses. CB4211 analog showed good tolerability in a 4-week human trial.
Side effects are generally consistent regardless of the specific application. See our MOTS-C side effects guide for details.
Calculate Your MOTS-C Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MOTS-C.
Open Calculator →Bottom Line: MOTS-C for Skin
MOTS-C shows preliminary research potential for skin. Standard protocols (5-10 mg per week, 2-3 times weekly, 8-12 weeks with 8-12 week breaks) apply.
Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.
Complete Guide
MOTS-c: The Metabolic Mitochondrial Peptide
Related Reading
- MOTS-C Dosage Guide
- MOTS-C Benefits
- MOTS-C Side Effects
- MOTS-C Stacking Guide
- MOTS-C Cycle Guide
- MOTS-C Research
Research-Grade Sourcing
If you're going to research MOTS-C, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is MOTS-C?
MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is a Mitochondrial-derived peptide, metabolic regulator. Encoded by the 12S rRNA region of the mitochondrial genome; naturally produced in response to stress, exercise, and aging. It is researched for improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility.
What is the recommended MOTS-C dosage?
Common dosages: 5-10 mg per week administered 2-3 times weekly via subcutaneous injection. Cycle length: 8-12 weeks with 8-12 week breaks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of MOTS-C?
Generally well-tolerated. Mild injection site reactions and transient digestive disturbances at higher doses. CB4211 analog showed good tolerability in a 4-week human trial.
Is MOTS-C safe?
MOTS-C has shown a favorable safety profile in research. Not FDA-approved. Listed by FDA as unlawful for compounding. Available as research chemical only. All research should follow appropriate safety protocols.